Karyopharm Therapeutics Inc. (KPTI)
NASDAQ·Healthcare·Biotechnology
$8.57
-1.04%
Mkt Cap $73.93M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $35.10M | $34.08M | -2.92% | -$2.26 | -$3.60 | -59.29% | — | — |
| Q4 2025 Nov 3, 2025 | $42.06M | $44.04M | +4.71% | -$3.47 | -$3.82 | -10.09% | — | — |
| Q3 2025 Aug 11, 2025 | $39.56M | $37.93M | -4.13% | -$3.80 | -$4.32 | -13.68% | — | — |
| Q2 2025 May 12, 2025 | $35.12M | $30.02M | -14.54% | -$4.21 | -$2.77 | +34.20% | — | — |
| Q1 2025 Feb 19, 2025 | $37.83M | $30.54M | -19.26% | -$3.90 | -$3.60 | +7.69% | — | — |
| Q4 2024 Nov 5, 2024 | $38.20M | $38.78M | +1.54% | -$4.05 | -$3.90 | +3.70% | — | — |
| Q3 2024 Aug 6, 2024 | $36.18M | $42.79M | +18.26% | -$4.35 | -$3.00 | +31.03% | — | — |
| Q2 2024 May 8, 2024 | $34.47M | $33.13M | -3.90% | -$4.95 | -$4.80 | +3.03% | — | — |
| Q1 2024 Feb 29, 2024 | $35.40M | $33.75M | -4.67% | -$4.35 | -$5.40 | -24.14% | — | — |
| Q4 2023 Nov 2, 2023 | $37.28M | $36.01M | -3.41% | -$4.20 | -$4.50 | -7.14% | — | — |
| Q3 2023 Aug 2, 2023 | $36.01M | $37.58M | +4.36% | -$5.10 | -$4.35 | +14.71% | — | — |
| Q2 2023 May 4, 2023 | $36.60M | $38.70M | +5.73% | -$5.10 | -$4.50 | +11.76% | — | — |
| Q1 2023 Feb 15, 2023 | $34.43M | $33.58M | -2.46% | -$5.10 | -$6.45 | -26.47% | — | — |
| Q4 2022 Nov 3, 2022 | $34.83M | $36.15M | +3.78% | -$8.40 | -$6.75 | +19.64% | — | — |
| Q3 2022 Aug 4, 2022 | $35.96M | $39.68M | +10.33% | -$9.45 | -$9.30 | +1.59% | — | — |
| Q2 2022 May 5, 2022 | $34.41M | $47.67M | +38.54% | -$9.45 | -$7.95 | +15.87% | — | — |
| Q1 2022 Feb 8, 2022 | $52.71M | $126.27M | +139.54% | -$6.00 | $6.90 | +215.00% | — | — |
| Q4 2021 Nov 3, 2021 | $25.80M | $37.69M | +46.08% | -$10.19 | -$10.34 | -1.47% | — | — |
| Q3 2021 Aug 5, 2021 | $22.60M | $22.60M | +0.00% | -$10.79 | -$10.64 | +1.39% | — | — |
| Q2 2021 May 3, 2021 | $26.57M | $23.26M | -12.46% | -$10.49 | -$11.54 | -10.01% | — | — |